Copper and Ceruloplasmin (Cp) Concentrations During the Acute Inflammatory Process in the Rat

Overview

Journal Agents Actions

Specialty Pharmacology

Date 1982 Jul 1

PMID 7136956

Citations 14

Authors

A Conforti

L Franco

R Milanino

G P Velo

Affiliations

Soon will be listed here.

Abstract

We have measured the concentration of copper and ceruloplasmin in serum of rats with carrageenan foot-oedema and in serum and exudate of rats with carrageenan pleurisy. Both serum copper and ceruloplasmin were found to increase in both models of inflammation. In these experimental conditions we have shown a strong positive correlation between copper and ceruloplasmin, in the serum of both normal and inflamed rats.

Citing Articles

The Role of Copper and Zinc Toxicity in Innate Immune Defense against Bacterial Pathogens.

Djoko K, Ong C, Walker M, McEwan A J Biol Chem. 2015; 290(31):18954-61.

PMID: 26055706 PMC: 4521016. DOI: 10.1074/jbc.R115.647099.

Exploiting innate immune cell activation of a copper-dependent antimicrobial agent during infection.

Festa R, Helsel M, Franz K, Thiele D Chem Biol. 2014; 21(8):977-87.

PMID: 25088681 PMC: 4170187. DOI: 10.1016/j.chembiol.2014.06.009.

Ceruloplasmin induces polymorphonuclear leukocyte priming in localized aggressive periodontitis.

Iwata T, Kantarci A, Yagi M, Jackson T, Hasturk H, Kurihara H J Periodontol. 2009; 80(8):1300-6.

PMID: 19656030 PMC: 2774796. DOI: 10.1902/jop.2009.090092.

Therapeutic management of copper deficiency in buffalo heifers: impact on immune function.

Sharma M, Joshi C, Das G Vet Res Commun. 2007; 32(1):49-63.

PMID: 17701079 DOI: 10.1007/s11259-007-9002-1.

Copper and zinc body levels in inflammation: an overview of the data obtained from animal and human studies.

Milanino R, Marrella M, Gasperini R, Pasqualicchio M, Velo G Agents Actions. 1993; 39(3-4):195-209.

PMID: 8304248 DOI: 10.1007/BF01998974.

References

WALKER W, Keats D . An investigation of the therapeutic value of the 'copper bracelet'-dermal assimilation of copper in arthritic/rheumatoid conditions. Agents Actions. 1976; 6(4):454-9. View

Sorenson J . Evaluation of copper complexes as potential anti-arthritic drugs. J Pharm Pharmacol. 1977; 29(7):450-2. DOI: 10.1111/j.2042-7158.1977.tb11367.x. View

Wintrobe M, CARTWRIGHT G, GUBLER C . Studies on the function and metabolism of copper. J Nutr. 1953; 50(4):395-419. DOI: 10.1093/jn/50.4.395. View

Milanino R, Conforti A, Fracasso M, Franco L, Leone R, Passarella E . Concerning the role of endogenous copper in the acute inflammatory process. Agents Actions. 1979; 9(5-6):581-8. DOI: 10.1007/BF01968131. View

Scudder P, McMurray W, White A, Dormandy T . Synovial fluid copper and related variables in rheumatoid and degenerative arthritis. Ann Rheum Dis. 1978; 37(1):71-2. PMC: 1000193. DOI: 10.1136/ard.37.1.71. View

Lewis A . A comparison of the anti-inflammatory effects of copper aspirinate and other copper salts in the rat and guinea pig. Agents Actions. 1978; 8(3):244-50. DOI: 10.1007/BF01966610. View

HARRIS E, Odell B . Copper and amine oxidases in connective tissue metabolism. Adv Exp Med Biol. 1974; 48(0):267-84. DOI: 10.1007/978-1-4684-0943-7_13. View

Deyl Z, Rosmus J, Adam M . Investigation on the reaction of metals with collagen in vivo. Eur J Biochem. 1970; 13(3):589-92. DOI: 10.1111/j.1432-1033.1970.tb00965.x. View

Bieganski T, Blasinska M, Kusche J . Determination of histaminase (diamine oxidase) activity by o-dianisidine test: interference of ceruloplasmin. Agents Actions. 1977; 7(1):85-92. DOI: 10.1007/BF01964886. View

10.

McCord J . Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science. 1974; 185(4150):529-31. DOI: 10.1126/science.185.4150.529. View

11.

Parker M, Humoller F, MAHLER D . Determination of copper and zinc in biological material. Clin Chem. 1967; 13(1):40-8. View

12.

LAHEY M, GUBLER C, CARTWRIGHT G, Wintrobe M . Studies on copper metabolism. VII. Blood copper in pregnancy and various pathologic states. J Clin Invest. 1953; 32(4):329-39. PMC: 438346. DOI: 10.1172/JCI102743. View

13.

DENKO C . Protective role of ceruloplasmin in inflammation. Agents Actions. 1979; 9(4):333-6. DOI: 10.1007/BF01970657. View

14.

Scudder P, Al-Timimi D, McMurray W, White A, Zoob B, Dormandy T . Serum copper and related variables in rheumatoid arthritis. Ann Rheum Dis. 1978; 37(1):67-70. PMC: 1000192. DOI: 10.1136/ard.37.1.67. View

15.

Sorenson J . Copper complexes - a unique class of anti-arthritic drugs. Prog Med Chem. 1978; 15:211-60. DOI: 10.1016/s0079-6468(08)70257-1. View

16.

Podhradska M, Podhradsky D, ANDRASINA J . Effect of inflammation on serum glycoproteins in rabbits. Folia Biol (Praha). 1976; 22(5):312-9. View

17.

Lee R, Lands W . Cofactors in the biosynthesis of prostaglandins F and F . Biochim Biophys Acta. 1972; 260(2):203-11. DOI: 10.1016/0005-2760(72)90033-1. View

18.

Rainsford K, Whitehouse M . Concerning the merits of copper aspirin as a potential anti-inflammatory drug. J Pharm Pharmacol. 1976; 28(1):83-6. DOI: 10.1111/j.2042-7158.1976.tb04035.x. View

19.

Beveridge S, WALKER W, Whitehouse M . Anti-inflammatory activity of copper salicylates applied to rats percutaneously in dimethyl sulphoxide with glycerol. J Pharm Pharmacol. 1980; 32(6):425-7. DOI: 10.1111/j.2042-7158.1980.tb12957.x. View

20.

Jayson M, Davis P, Whicher J, Walters G . Serum copper and caeruloplasmin in ankylosing spondylitis, systemic sclerosis, and morphea. Ann Rheum Dis. 1975; 35(5):443-5. PMC: 1006577. DOI: 10.1136/ard.35.5.443. View